AI Article Synopsis

  • Concerns about glyphosate, a common herbicide, and its potential health risks are investigated through a study on rats.
  • Pregnant rats exposed to glyphosate were found to have offspring with significantly reduced serum melatonin levels and oxidative stress-related changes in the brain's striatum.
  • The study highlights a possible link between glyphosate exposure, decreased melatonin secretion, and an increased risk of neurodegenerative disorders, emphasizing the need to address the effects of environmental contaminants on hormonal systems.

Article Abstract

Concerns have been raised regarding the potential adverse health effects of the ubiquitous herbicide glyphosate. Here, we investigated long-term effects of developmental exposure to a glyphosate-based herbicide (GBH) by analyzing serum melatonin levels and cellular changes in the striatum of adult male rats (90 days old). Pregnant and lactating rats were exposed to 3% GBH (0.36% glyphosate) through drinking water from gestational day 5 to postnatal day 15. The offspring showed reduced serum melatonin levels (43%) at the adult age compared with the control group. The perinatal exposure to GBH also induced long-term oxidative stress-related changes in the striatum demonstrated by increased lipid peroxidation (45%) and DNA/RNA oxidation (39%) together with increased protein levels of the antioxidant enzymes, superoxide dismutase (SOD1, 24%), glutamate-cysteine ligase (GCLC, 58%), and glutathione peroxidase 1 (GPx1, 31%). Moreover, perinatal GBH exposure significantly increased the total number of neurons (20%) and tyrosine hydroxylase (TH)-positive neurons (38%) in the adult striatum. Mechanistic in vitro studies with primary rat pinealocytes exposed to 50 µM glyphosate demonstrated a decreased melatonin secretion partially through activation of metabotropic glutamate receptor 3 (mGluR3), while higher glyphosate levels (100 or 500 µM) also reduced the pinealocyte viability. Since decreased levels of the important antioxidant and neuroprotector melatonin have been associated with an increased risk of developing neurodegenerative disorders, this demonstrates the need to consider the melatonin hormone system as a central endocrine-related target of glyphosate and other environmental contaminants.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604376PMC
http://dx.doi.org/10.3390/antiox12101825DOI Listing

Publication Analysis

Top Keywords

melatonin levels
12
long-term effects
8
perinatal exposure
8
exposure glyphosate-based
8
glyphosate-based herbicide
8
adult male
8
male rats
8
serum melatonin
8
changes striatum
8
levels antioxidant
8

Similar Publications

Objective: The objective of this systematic review and meta-analysis was to assess the efficacy of melatonin in drug- or contrast-induced AKI in preclinical and clinical studies.

Methods: PubMed, Embase, Scopus, Web of Science (WOS), the Cochrane Database of Systematic Reviews (CDSR), and clinical trials.GOV from the beginning until August 1, 2024.

View Article and Find Full Text PDF

Background: Disruption in diurnal rest‐activity rhythms is a hallmark of Alzheimer’s disease. Currently, we know little about how physiology, symptoms, and biomarkers change over the 24‐hour day in people living with Alzheimer’s disease. In particular, we don’t know whether plasma biomarkers of neurodegeneration, which offer promise as diagnostic or stratification tools, vary with time of day, and whether these associate with the circadian markers melatonin and cortisol.

View Article and Find Full Text PDF

Background: This study investigates the impact of IGC‐AD1, a combination comprising of low concentration of delta‐9 tetrahydrocannabinol (“THC”) and melatonin on blood serum potassium levels in patients with Alzheimer’s disease (“AD”). Loss of intracellular compartmentalization of potassium is a characteristic of AD pathology, with supporting studies indicating significantly lower potassium levels in intracellular compartments of AD brains and an associated increase in serum potassium levels in AD subjects. Here, we present preliminary safety lab data from a Phase I trial of AD patients administered with IGC‐AD1.

View Article and Find Full Text PDF

Background: IGC‐AD1 comprises of Tetrahydrocannabinol (“THC”) and melatonin. The two active pharmaceuticals are known for their neuroprotective properties. In this analysis we studied multiple dosing of IGC‐AD1 in Alzheimer’s (“AD”) populations vulnerable to hepatic complications.

View Article and Find Full Text PDF

Background: Effect of dynamic lighting on sleep were studied since 1980’s. Traditional light sources were used due to lack of advancement in technology and also researchers assumed illuminance as cause of melatonin suppression. This led researchers to use high illuminance to suppress melatonin at day time.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!